Details

Autor(en) / Beteiligte

• Baldini, Enke
• Tuccilli, Chiara
• Prinzi, Natalie
• Sorrenti, Salvatore
• Falvo, Laura
• De Vito, Corrado
• Catania, Antonio
• Tartaglia, Francesco
• Mocini, Renzo
• Coccaro, Carmela
• Alessandrini, Stefania
• Barollo, Susi
• Mian, Caterina
• Antonelli, Alessandro
• De Antoni, Enrico
• D'Armiento, Massimino
• Ulisse, Salvatore
• Angelucci, Adriano

Titel

Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients

Ist Teil von

• PloS one, 2015-03, Vol.10 (3), p.e0121514-e0121514

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2015

Quelle

MEDLINE

Beschreibungen/Notizen

• A number of reports indicated that Aurora-A or Aurora-B overexpression represented a negative prognostic factor in several human malignancies. In thyroid cancer tissues a deregulated expression of Aurora kinases has been also demonstrated, but no information regarding its possible prognostic role in differentiated thyroid cancer is available. Here, we evaluated Aurora-A and Aurora-B mRNA expression and its prognostic relevance in a series of 87 papillary thyroid cancers (PTC), with a median follow-up of 63 months. The analysis of Aurora-A and Aurora-B mRNA levels in PTC tissues, compared to normal matched tissues, revealed that their expression was either up- or down-regulated in the majority of cancer tissues. In particular, Aurora-A and Aurora-B mRNA levels were altered, respectively, in 55 (63.2%) and 79 (90.8%) out of the 87 PTC analyzed.A significant positive correlation between Aurora-A and Aurora-B mRNAs was observed (p=0.001). The expression of both Aurora genes was not affected by the BRAFV600E mutation. Univariate, multivariate and Kaplan-Mayer analyses documented the lack of association between Aurora-A or Aurora-B expression and clinicopathological parameters such as gender, age, tumor size, histology, TNM stage, lymph node metastasis and BRAF status as well as disease recurrences or disease-free interval. Only Aurora-B mRNA was significantly higher in T(3-4) tissues, with respect to T(1-2) PTC tissues. The data reported here demonstrate that the expression of Aurora kinases is deregulated in the majority of PTC tissues, likely contributing to PTC progression. However, differently from other human solid cancers, detection of Aurora-A or Aurora-B mRNAs is not a prognostic biomarker in PTC patients.